Diffusion-weighted MRI in Crohn's disease: Current status and recommendations

Abstract : Over the past years, technological improvements and refinements in magnetic resonance imaging (MRI) hardware have made high-quality diffusion-weighted imaging (DWI) routinely possible for the bowel. DWI is promising for the detection and characterization of lesions in Crohn's disease (CD) and has been advocated as an alternative to intravenous gadolinium-based contrast agents. Furthermore, quantification using the apparent diffusion coefficient may have value as a biomarker of CD activity and has shown promise. In this article we critically review the literature pertaining to the value of DWI in CD for detection, characterization, and quantification of disease activity and complications. Although the body of supportive evidence is growing, it is clear that well-designed, multicenter studies are required before the role of DWI in clinical practice can be fully established. J. Magn. Reson. Imaging 2016;44:1381-1396.
Type de document :
Article dans une revue
Journal of Magnetic Resonance Imaging, Wiley-Blackwell, 2016, 44 (6), pp.1381 - 1396. 〈10.1002/jmri.25325〉
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-01643992
Contributeur : Céline Breton <>
Soumis le : mardi 21 novembre 2017 - 19:04:27
Dernière modification le : jeudi 14 décembre 2017 - 08:38:04

Identifiants

Citation

Anthony Dohan, Stuart Taylor, Christine Hoeffel, Maximilien Barret, Matthieu Allez, et al.. Diffusion-weighted MRI in Crohn's disease: Current status and recommendations. Journal of Magnetic Resonance Imaging, Wiley-Blackwell, 2016, 44 (6), pp.1381 - 1396. 〈10.1002/jmri.25325〉. 〈hal-01643992〉

Partager

Métriques

Consultations de la notice

46